Navidea Biopharmaceuticals Inc (OTCPK:NAVB)
$ 0.0001 0 (0%) Market Cap: 10,000.00 Enterprise Value: -2.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2022 Navidea Biopharmaceuticals Inc Earnings Call Transcript

Mar 21, 2023 / 09:00PM GMT
Release Date Price: $0.3399 (+12.18%)
Operator

Greetings, and welcome to the Navidea Biopharmaceuticals Fourth Quarter Earnings Call and Business Update. (Operator Instructions) And as a reminder, this conference is being recorded.

It is now my pleasure to introduce to you, Dr. Michael Rosol, Chief Medical Officer. Thank you, Mike. You may begin.

Michael Stanley Rosol
Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer

Thank you, and thank you all for joining us here today for the earnings call and business update. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following prepared remarks, we will be conducting a live Q&A session, as you've just heard.

Navidea's Chair of its Board of Directors, Mr. Alex Cappello; the Vice Chair of its Board of Directors, Mr. Kim Scott; its Vice President of Finance and Administration, Ms. Erika Eves; and its controller, Mr. Joe Meyer, are all joining me on the call today.

During the course of this conference call, we will be making forward-looking statements regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot